Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
Takeda, Lilly-Innovent, BIO-China—Fierce Pharma Asia
Takeda launched a restructuring. Innovent notched positive data for a GLP-1R/GCGR agonist. BIO warned of the harm from cutting off Chinese CDMOs.
Angus Liu
May 10, 2024 9:30am
Rexulti the surprise winner in April's TV drug ad spending list
May 7, 2024 9:40am
Lilly catches Indiana Fever with jersey, health equity collab
May 2, 2024 2:07pm
Novo Nordisk scales Wegovy supply amid pressure from Lilly
May 2, 2024 11:56am
Lilly: Zepbound, Mounjaro supply to remain tight through 2024
Apr 30, 2024 12:03pm
Lilly’s growth drivers, Verzenio and Jardiance, suffer setbacks
Apr 30, 2024 10:48am